9 relations: Clinical trial, Eisai (company), Hypocretin (orexin) receptor 1, Hypocretin (orexin) receptor 2, Insomnia, List of investigational sleep drugs, Orexin, Orexin antagonist, Orexin receptor.
Clinical trials are experiments or observations done in clinical research.
is a Japanese pharmaceutical company headquartered in Tokyo, Japan.
Orexin receptor type 1 (Ox1R or OX1), also known as hypocretin receptor type 1 (HcrtR1), is a protein that in humans is encoded by the HCRTR1 gene.
Orexin receptor type 2 (Ox2R or OX2), also known as hypocretin receptor type 2 (HcrtR2), is a protein that in humans is encoded by the HCRTR2 gene.
Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping.
This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved.
Orexin, also known as hypocretin, is a neuropeptide that regulates arousal, wakefulness, and appetite.
An orexin receptor antagonist is a drug that inhibits the effect of orexin by acting as a receptor antagonist of the orexin receptor.
The orexin receptor (also referred to as the hypocretin receptor) is a G-protein-coupled receptor that binds the neuropeptide orexin.